What's in Azienda Ospedaliera di Padova's pipeline?

Azienda Ospedaliera di Padova has 3 drugs in our index: 2 marketed, 0 filed, 0 in Phase 3, 1 in Phase 2, 0 in Phase 1.

Which companies overlap with Azienda Ospedaliera di Padova's portfolio?

Top competitors by shared drug class: Allergan, American University of Beirut Medical Center, China International Neuroscience Institution, Daewoong Pharmaceutical Co. LTD., Eye & ENT Hospital of Fudan University.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/azienda-ospedaliera-di-padova.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-18 · How we verify

Azienda Ospedaliera di Padova — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Azienda Ospedaliera di Padova pipeline: 2 marketed, 0 filed, 0 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 0 Phase 3 1 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
dexmedetomidine (IN)	dexmedetomidine (IN)	marketed	Alpha-2 adrenergic receptor agonist	Alpha-2 adrenergic receptor	Anesthesia and Critical Care
peginterferon plus ribavirin	peginterferon plus ribavirin	marketed

Therapeutic area mix

Anesthesia and Critical Care · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Allergan · 1 shared drug class
American University of Beirut Medical Center · 1 shared drug class
China International Neuroscience Institution · 1 shared drug class
Daewoong Pharmaceutical Co. LTD. · 1 shared drug class
Eye & ENT Hospital of Fudan University · 1 shared drug class
Fayoum University Hospital · 1 shared drug class
First Affiliated Hospital of Chongqing Medical University · 1 shared drug class
Ain Shams University · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Azienda Ospedaliera di Padova:

Cite this brief

Drug Landscape (2026). Azienda Ospedaliera di Padova — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/azienda-ospedaliera-di-padova. Accessed 2026-05-18.